Koh Wee Ling, Foster Thomas, Mooranian Armin, Al-Salami Hani
Royal Perth Hospital, East Metropolitan Health Service, Perth, Western Australia, Australia.
Biotechnology & Drug Development Research Laboratory, Curtin Medical School & Curtin Health Innovation Research Institute, Curtin University, Perth, Western Australia, Australia.
Ther Deliv. 2022 Dec;13(12):591-604. doi: 10.4155/tde-2022-0044. Epub 2023 Mar 2.
Chronic disorders such as diabetes mellitus are associated with multiple organ dysfunction, including retinopathy, neuropathy, nephropathy, peripheral vascular disease, and vascular disease. Lifelong subcutaneous insulin injections are currently the only treatment option for patients with Type 1 diabetes mellitus, and it poses numerous challenges. Since the breakthrough achieved from the Edmonton protocol in the year 2000, there has been important research to investigate whether islet cell transplantation can achieve long-term normoglycemia in patients without the need for insulin. The use of biopolymeric scaffold to enclose islet cells has also been explored to improve survivability and viability of islet cells. This review paper summarizes the latest research in using biopolymeric scaffolds in islet transplantation and how microfluidic devices can assist.
糖尿病等慢性疾病与多器官功能障碍相关,包括视网膜病变、神经病变、肾病、外周血管疾病和血管疾病。终身皮下注射胰岛素是目前1型糖尿病患者唯一的治疗选择,且这带来了诸多挑战。自2000年埃德蒙顿方案取得突破以来,已有重要研究探讨胰岛细胞移植能否使患者在无需胰岛素的情况下实现长期血糖正常。人们也在探索使用生物聚合物支架包裹胰岛细胞,以提高胰岛细胞的存活率和活力。这篇综述文章总结了在胰岛移植中使用生物聚合物支架的最新研究以及微流控设备如何提供帮助。